Systemic nano-delivery of low-dose STING agonist targeted to CD103+ dendritic cells for cancer immunotherapy
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference57 articles.
1. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies;Galon;Nat. Rev. Drug Discov.,2019
2. Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance;Park;Exp. Mol. Med.,2018
3. High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors;Maleki Vareki;J. Immunother. Cancer,2018
4. T cell-inflamed versus non-T cell-inflamed tumors: a conceptual framework for cancer immunotherapy drug development and combination therapy selection;Trujillo;Cancer Immunol. Res.,2018
5. Overall survival and long-term safety of Nivolumab (anti-programmed death 1 antibody, BMS-936558, ONO-4538) in patients with previously treated advanced non-small-cell lung cancer;Gettinger;J. Clin. Oncol.,2015
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting activation of cGAS-STING signaling pathway by engineered biomaterials for enhancing cancer immunotherapy;Materials Today;2024-09
2. The current role of dendritic cells in the progression and treatment of colorectal cancer;Cancer Biology & Medicine;2024-08-22
3. Activated STING-containing R-EVs from iPSC-derived MSCs promote antitumor immunity;Cancer Letters;2024-08
4. Capecitabine loaded potato starch-chitosan nanoparticles: A novel approach for targeted therapy and improved outcomes in aggressive colon cancer;European Journal of Pharmaceutics and Biopharmaceutics;2024-07
5. Intravenous delivery of STING agonists using acid-sensitive polycationic polymer-modified lipid nanoparticles for enhanced tumor immunotherapy;Acta Pharmaceutica Sinica B;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3